(1-(1,1-Dioxidotetrahydrothiophen-3-yl)-3-methyl-6-(thiophen-2-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)(4-methylpiperidin-1-yl)methanone

Catalog No. :
ACQYRO452
CAS No. :
1021089-95-1
Molecular Formula :
C22H26N4O3S2
Molecular Weight :
458.61

IUPAC Name:(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-6-(thiophen-2-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)(4-methylpiperidin-1-yl)methanone

(1-(1,1-Dioxidotetrahydrothiophen-3-yl)-3-methyl-6-(thiophen-2-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)(4-methylpiperidin-1-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-(1,1-Dioxidotetrahydrothiophen-3-yl)-3-methyl-6-(thiophen-2-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)(4-methylpiperidin-1-yl)methanone
IUPAC Name(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-6-(thiophen-2-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)(4-methylpiperidin-1-yl)methanone
Molecular FormulaC22H26N4O3S2
Molecular Weight458.61
SMILESO=C(C1=C2C(N(C(CC3)CS3(=O)=O)N=C2C)=NC(C4=CC=CS4)=C1)N5CCC(C)CC5
InChI KeyCFTAFOQPSRVWKF-UHFFFAOYSA-N
Synonym[1-(1,1-dioxothiolan-3-yl)-3-methyl-6-thiophen-2-ylpyrazolo[3,4-b]pyridin-4-yl]-(4-methylpiperidin-1-yl)methanone
CAS No.1021089-95-1

Synthetic Route by SureRoute

1. ACQYRO452 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQYRO452 route product structure diagram
    ACQYRO4521021089-95-1
Inquiry

2. ACQYRO452 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXRB496 route compound structure diagram
    ACUXRB4966165-68-0 In Stock
  4. Then
  5. ACQYRO452 route product structure diagram
    ACQYRO4521021089-95-1
Inquiry

Comments (0)